PVLA
Palvella Therapeutics, Inc.Company with tickers: PVLA
CIK
1583648
CUSIP
697947109
Shares Outstanding
14,342,844
13F Activity (30d)
144 filings
142 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-K | 2022-03-02 | 2021-12-31 | |
| 10-Q | 2022-05-11 | 2022-03-31 | |
| 8-K | 2022-05-11 | — | |
| 8-K/A | 2022-05-12 | 2022-05-11 | |
| 8-K | 2022-05-25 | — | |
| 8-K | 2022-06-08 | — | |
| 8-K | 2022-06-27 | 2022-06-22 | |
| 10-K/A | 2022-07-06 | 2021-12-31 | |
| 8-K | 2022-08-04 | — | |
| 10-Q | 2022-08-04 | 2022-06-30 | |
| 8-K | 2022-09-13 | — | |
| 8-K | 2022-11-01 | — | |
| 8-K | 2022-11-02 | — | |
| 10-Q | 2022-11-04 | 2022-09-30 | |
| 8-K | 2022-11-04 | — | |
| 8-K | 2023-01-10 | — | |
| 8-K | 2023-03-29 | — | |
| 10-K | 2023-03-31 | 2022-12-31 | |
| 8-K | 2023-05-10 | — | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| 8-K | 2023-05-19 | 2023-05-15 | |
| 8-K | 2023-06-08 | — | |
| 8-K | 2023-06-21 | — | |
| 8-K | 2023-06-26 | 2023-06-21 | |
| 8-K | 2023-07-13 | — | |
| 8-K | 2023-07-18 | 2023-07-17 | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K/A | 2023-08-31 | 2023-07-17 | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-12-21 | 2023-12-15 | |
| 8-K | 2024-03-27 | — | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2024-04-18 | — | |
| 10-K/A | 2024-04-29 | 2023-12-31 | |
| 8-K | 2024-05-09 | 2024-05-07 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-07-03 | 2024-06-28 | |
| 8-K | 2024-07-24 | 2024-07-23 | |
| 8-K | 2024-08-08 | 2024-08-07 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-10-03 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-12-03 | 2024-12-02 | |
| 8-K | 2024-12-12 | 2024-12-11 | |
| 8-K | 2024-12-16 | 2024-12-13 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-03-04 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-31 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 |
Showing 51–100 of 123 filings